Diversified Trust Co Acquires 32,436 Shares of Ventas, Inc. $VTR

Diversified Trust Co lifted its holdings in shares of Ventas, Inc. (NYSE:VTR) by 766.1% during the 1st quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 36,670 shares of the real estate investment trust’s stock after purchasing an additional 32,436 shares during the quarter. Diversified Trust Co’s holdings in Ventas were worth $2,999,000 as of its most recent SEC filing.

Several other institutional investors have also made changes to their positions in the stock. Bridgewater Advisors Inc. increased its stake in Ventas by 2.0% during the 4th quarter. Bridgewater Advisors Inc. now owns 6,790 shares of the real estate investment trust’s stock worth $525,000 after acquiring an additional 133 shares during the period. IHT Wealth Management LLC grew its holdings in shares of Ventas by 3.2% during the 4th quarter. IHT Wealth Management LLC now owns 4,415 shares of the real estate investment trust’s stock worth $343,000 after purchasing an additional 137 shares in the last quarter. True Wealth Design LLC grew its holdings in shares of Ventas by 32.0% during the 4th quarter. True Wealth Design LLC now owns 569 shares of the real estate investment trust’s stock worth $44,000 after purchasing an additional 138 shares in the last quarter. Cigna Investments Inc. New raised its stake in Ventas by 3.3% in the fourth quarter. Cigna Investments Inc. New now owns 4,396 shares of the real estate investment trust’s stock valued at $341,000 after purchasing an additional 142 shares in the last quarter. Finally, Parallel Advisors LLC lifted its position in Ventas by 4.6% during the third quarter. Parallel Advisors LLC now owns 3,970 shares of the real estate investment trust’s stock worth $278,000 after purchasing an additional 175 shares during the period. 94.18% of the stock is currently owned by institutional investors.

Wall Street Analysts Forecast Growth

A number of brokerages have issued reports on VTR. Jefferies Financial Group increased their price objective on shares of Ventas from $97.00 to $100.00 and gave the stock a “buy” rating in a research note on Tuesday, May 12th. KeyCorp upped their price target on shares of Ventas from $90.00 to $95.00 and gave the stock an “overweight” rating in a report on Thursday, May 7th. Royal Bank Of Canada increased their price target on shares of Ventas from $91.00 to $98.00 and gave the stock an “outperform” rating in a research report on Monday, May 4th. Weiss Ratings reissued a “buy (b-)” rating on shares of Ventas in a research note on Friday, March 27th. Finally, Raymond James Financial began coverage on Ventas in a research note on Tuesday, June 16th. They set an “outperform” rating and a $94.00 target price for the company. Fifteen analysts have rated the stock with a Buy rating and three have given a Hold rating to the company. According to MarketBeat.com, Ventas currently has a consensus rating of “Moderate Buy” and an average target price of $96.00.

Ventas Stock Up 0.0%

Shares of NYSE:VTR opened at $81.61 on Monday. Ventas, Inc. has a 52-week low of $61.76 and a 52-week high of $91.06. The company has a market capitalization of $39.68 billion, a PE ratio of 148.38, a price-to-earnings-growth ratio of 1.75 and a beta of 0.71. The company has a debt-to-equity ratio of 0.95, a quick ratio of 0.25 and a current ratio of 0.25. The company has a fifty day moving average of $85.07 and a 200-day moving average of $82.59.

Ventas (NYSE:VTR) last released its quarterly earnings data on Monday, April 27th. The real estate investment trust reported $0.11 earnings per share for the quarter, missing the consensus estimate of $0.12 by ($0.01). The firm had revenue of $1.65 billion for the quarter, compared to analyst estimates of $1.59 billion. Ventas had a net margin of 4.25% and a return on equity of 2.09%. The company’s revenue was up 22.0% compared to the same quarter last year. During the same period last year, the business earned $0.84 EPS. Ventas has set its FY 2026 guidance at 3.820-3.890 EPS. On average, equities analysts predict that Ventas, Inc. will post 3.88 EPS for the current fiscal year.

Ventas Dividend Announcement

The company also recently declared a quarterly dividend, which will be paid on Thursday, July 16th. Stockholders of record on Tuesday, June 30th will be paid a dividend of $0.52 per share. This represents a $2.08 dividend on an annualized basis and a dividend yield of 2.5%. The ex-dividend date of this dividend is Tuesday, June 30th. Ventas’s dividend payout ratio (DPR) is presently 378.18%.

Insider Activity

In other news, Director Walter C. Rakowich sold 1,152 shares of the business’s stock in a transaction dated Thursday, May 14th. The stock was sold at an average price of $90.20, for a total transaction of $103,910.40. Following the sale, the director directly owned 28,349 shares in the company, valued at approximately $2,557,079.80. The trade was a 3.90% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is accessible through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, Director Michael J. Embler acquired 2,500 shares of the stock in a transaction dated Wednesday, June 3rd. The stock was purchased at an average cost of $78.81 per share, with a total value of $197,025.00. Following the purchase, the director directly owned 19,202 shares of the company’s stock, valued at $1,513,309.62. This trade represents a 14.97% increase in their ownership of the stock. The disclosure for this purchase is available in the SEC filing. Insiders own 0.53% of the company’s stock.

Ventas Company Profile

Ventas, Inc (NYSE: VTR) is a real estate investment trust (REIT) that specializes in healthcare-related real estate. The company acquires, owns and manages a diversified portfolio of properties serving the healthcare continuum, including senior housing communities, skilled nursing facilities, medical office buildings, life science and research centers, and other properties leased to healthcare providers and operators. Ventas generates revenue through long-term leases, property management and selective development activities focused on meeting the real estate needs of the healthcare sector.

Ventas’ business model combines property ownership with active asset management and capital markets activity.